Skip to main content

Table 2 Associations between MTC02 expression results and ERG negative prostate cancer phenotype

From: High mitochondria content is associated with prostate cancer disease progression

   MCT02 IHC result  
Parameter n evaluable Negative (%) Weak (%) Moderate (%) Strong (%) p value
All cancers 4.15 4.2 17.1 34.2 44.5  
PSA preoperative       
<4 423 4.02 18.2 33.57 44.21 0.0372
4-10 2.43 3.88 17.94 35.42 42.76
10-20 925 5.08 16.11 32.76 46.05
>20 337 3.56 12.76 31.16 52.52
Tumor stage       
pT2 2.74 4.42 20.02 36.24 39.31 < 0.0001
pT3a 859 4.07 13.62 32.83 49.48
pT3b 515 3.3 8.16 25.83 62.72
pT4 26 0 7.69 30.77 61.54
Gleason grade       
≤3 + 3 906 6.62 25.17 38.19 30.0 < 0.0001
3 + 4 2.32 3.67 17.02 36.29 43.02
4 + 3 685 3.5 11.09 26.86 58.54
≥4 + 4 226 1.77 3.98 19.91 74.34
Lymph node metastasis       
N0 2.41 4.28 16.09 33.85 45.78 < 0.0001
N+ 230 3.04 6.52 23.04 67.39
Surgical margin       
Negative 3.29 4.01 18.09 35.2 42.71 < 0.0001
Positive 783 4.34 13.28 29.89 52.49